Sutter Medizintechnik GmbH, based in Emmendingen, develops, manufactures and markets precision products for electrosurgery, including radiofrequency surgical devices for microsurgical applications. The product range includes, besides devices, a broad program of mono- and bipolar accessories such as bipolar forceps, clamps, electrodes and cables, which are used across numerous surgical disciplines. A marketing focus is on ENT, neurosurgery and plastic-reconstructive and aesthetic surgery, and at the end of 2023 Sutter Medizintechnik employed 147 persons, including 3 apprentices. Sutter Medizintechnik GmbH is a family business.
Die Vertretung, der Handel, die Entwicklung und die Herstellung von medizinisch-technischen Geräten und Instrumenten aller Art.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 775 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Bert Sutter | Geschäftsführer(in) | Emmendingen |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 775 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 02.06.2022 | Registered Seat Change | Emmendingen |
| 02.06.2022 | Business Address Change | Alfred-Walz-Straße 22, 79312 Emmendingen |
| 02.06.2022 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 20.03.2006 | Share Capital Set | — | 76.000 € |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 775 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€21.2M2 | €2,439,083 | €39,103,444 | — |
| 2023 | Rohergebnis€18.6M2 | €2,814,902 | €38,234,066 | — |
| 2022 | Rohergebnis€14M2 | €556,966 | €36,110,079 | — |
| 2021 | Rohergebnis€12.6M2 | €951,669 | €35,815,650 | — |
| 2020 | Rohergebnis€16.2M2 | €3,752,210 | €31,661,878 | — |
| 2019 | Rohergebnis€12.5M2 | €1,664,871 | €17,301,246 | — |
| 2018 | Rohergebnis€11.6M2 | €1,735,809 | €15,532,615 | — |
| 2017 | Rohergebnis€11.4M2 | €2,127,959 | €12,671,478 | — |
| 2016 | Rohergebnis€9.5M2 | €1,220,937 | €10,405,239 | — |
| 2015 | Rohergebnis€7.8M2 | €654,123 | €9,634,421 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 775 (as of 30 October 2026)
MAICO Diagnostics GmbH
Berlin · Herstellung von Bestrahlungs- und Elektrotherapiegeräten und elektromedizinischen Geräten
Eckert & Ziegler Eurotope GmbH
Berlin · Herstellung von allen anderen Maschinen für sonstige bestimmte Wirtschaftszweige a. n. g.
A.R.C. Laser GmbH
Nürnberg · Herstellung von Bestrahlungs- und Elektrotherapiegeräten und elektromedizinischen Geräten
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €10,381,771 | 86.2% |
| Depreciation | €1,519,164 | 12.6% |
| Interest & Similar | €137,476 | 1.1% |
